<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our previous studies using in situ end labeling (ISEL) of fragmented DNA revealed extensive apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> in the bone marrows (BM) of patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) involving both stromal and hematopoietic cells </plain></SENT>
<SENT sid="1" pm="."><plain>In the present report we show greater synthesis of interleukin-1 beta (IL-1 beta) in 4 hour cultures of density separated BM aspirate mononuclear (BMAM) cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients as compared to the cultures of <z:mpath ids='MPATH_458'>normal</z:mpath> BM from healthy donors or <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients (1.7 +/- 0.37 pg/10(5) cells, n = 29 v 0.42 +/- 0.24 pg/10(5) cells, n = 11, respectively, P = .049) </plain></SENT>
<SENT sid="2" pm="."><plain>Further, these amounts of IL-1 beta in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> showed a significant correlation with the extent of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> detected by ISEL in corresponding plastic embedded BM biopsies (r = .480, n = 30, P = .007) </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast <z:mpath ids='MPATH_458'>normal</z:mpath> BMs did not show any correlation between the two (r = .091, n = 12, P = .779) </plain></SENT>
<SENT sid="4" pm="."><plain>No significant correlation was found between the amounts of IL-1 beta and % S-phase cells (labeling index; LI%) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> determined in BM biopsies using immunohistochemistry following in vivo infusions of <z:chebi fb="0" ids="43448">iodo</z:chebi>- and/or bromodeoxyuridine </plain></SENT>
<SENT sid="5" pm="."><plain>Neither anti-IL-1 beta antibody nor IL-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> blocked the apoptotic <z:hpo ids='HP_0011420'>death</z:hpo> of BMAM cells in 4 hour cultures (n = 5) determined by ISEL (apoptotic index; AI%), although the latter led to a dose-dependent accumulation of active IL-1 beta in the culture supernatants </plain></SENT>
<SENT sid="6" pm="."><plain>On the other hand, a specific tetrapetide-<z:chebi fb="1" ids="17478">aldehyde</z:chebi> inhibitor of ICE significantly retarded the apoptotic <z:hpo ids='HP_0011420'>death</z:hpo> of BMAM cells at 1 mumol/L in 5/6 MDS cases studied (AI% = 2.99 +/- 0.30 in controls v 1.58 +/- 0.40 with ICE-inhibitor, P = .05) and also reduced the levels of active IL-1 beta synthesized (5.59 +/- 2.63 v 2.24 +/- 0.93 pg/10(6) cells, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> cells, neither IL-1 blockers nor the ICE inhibitor showed any effect on the marginal increase in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> observed in 4 hour cultures </plain></SENT>
<SENT sid="8" pm="."><plain>Our data thus suggest a possible involvement of an ICE-like protease in the intramedullary apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> in the BMs of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
</text></document>